Denali Therapeutics Stock Price History
| DNLI Stock | USD 24.50 0.19 0.77% |
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 24.50, as last reported on the 26th of November, with the highest price reaching 25.77 and the lowest price hitting 24.46 during the day.
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. Denali Therapeutics is very steady at the moment. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0168, which denotes the company had a 0.0168% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Coefficient Of Variation of 3174.18, downside deviation of 3.67, and Mean Deviation of 2.35 to check if the risk estimate we provide is consistent with the expected return of 0.0579%.
As of now, Denali Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Denali Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 0.63, while Total Stockholder Equity is projected to decrease to under 712.9 M. . The Denali Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.36, while Price To Sales Ratio is projected to decrease to 8.47. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of December 2017 | 200 Day MA 22.6171 | 50 Day MA 27.8774 | Beta 1.394 |
Denali |
Sharpe Ratio = 0.0168
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | DNLI | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.44 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Denali Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.6951 | Enterprise Value Ebitda (8.66) | Price Sales 3.3 K | Shares Float 130.1 M | Wall Street Target Price 41.6923 |
Denali Therapeutics Stock Price History Chart
There are several ways to analyze Denali Stock price data. The simplest method is using a basic Denali candlestick price chart, which shows Denali Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 31.58 |
| Lowest Price | November 18, 2024 | 24.18 |
Denali Therapeutics November 26, 2024 Stock Price Synopsis
Various analyses of Denali Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Denali Stock. It can be used to describe the percentage change in the price of Denali Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Denali Stock.| Denali Therapeutics Price Daily Balance Of Power | (0.15) | |
| Denali Therapeutics Price Rate Of Daily Change | 0.99 | |
| Denali Therapeutics Accumulation Distribution | 95,974 | |
| Denali Therapeutics Price Action Indicator | (0.71) |
Denali Therapeutics November 26, 2024 Stock Price Analysis
Denali Stock Price History Data
The price series of Denali Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 7.69 with a coefficient of variation of 7.91. Under current investment horizon, the daily prices are spread out with arithmetic mean of 27.35. The median price for the last 90 days is 27.08.| Open | High | Low | Close | Volume | ||
| 11/25/2024 | 25.17 | 25.77 | 24.46 | 24.50 | 1,887,986 | |
| 11/22/2024 | 24.32 | 24.73 | 23.97 | 24.69 | 830,354 | |
| 11/21/2024 | 24.38 | 24.79 | 23.80 | 24.22 | 1,477,768 | |
| 11/20/2024 | 24.18 | 24.83 | 23.82 | 24.42 | 767,970 | |
| 11/19/2024 | 24.00 | 24.37 | 23.53 | 24.34 | 1,011,754 | |
| 11/18/2024 | 25.07 | 25.35 | 24.06 | 24.18 | 1,156,707 | |
| 11/15/2024 | 28.38 | 28.62 | 25.00 | 25.05 | 1,103,218 | |
| 11/14/2024 | 29.63 | 29.80 | 28.29 | 28.45 | 831,295 | |
| 11/13/2024 | 30.05 | 30.88 | 29.26 | 29.63 | 1,587,971 | |
| 11/12/2024 | 31.07 | 31.47 | 29.50 | 29.89 | 934,442 | |
| 11/11/2024 | 32.00 | 33.33 | 31.56 | 31.58 | 797,116 | |
| 11/08/2024 | 29.26 | 31.46 | 29.02 | 31.35 | 713,529 | |
| 11/07/2024 | 29.25 | 31.41 | 29.02 | 29.60 | 885,922 | |
| 11/06/2024 | 28.98 | 29.60 | 28.23 | 29.55 | 1,031,187 | |
| 11/05/2024 | 26.17 | 27.70 | 26.17 | 27.65 | 556,620 | |
| 11/04/2024 | 26.91 | 27.63 | 26.76 | 27.21 | 607,245 | |
| 11/01/2024 | 26.65 | 27.49 | 26.27 | 27.05 | 837,711 | |
| 10/31/2024 | 26.64 | 26.74 | 25.55 | 25.96 | 557,245 | |
| 10/30/2024 | 27.22 | 27.64 | 26.83 | 26.85 | 576,418 | |
| 10/29/2024 | 27.64 | 27.74 | 26.98 | 27.47 | 1,756,257 | |
| 10/28/2024 | 26.50 | 27.80 | 26.23 | 27.78 | 810,036 | |
| 10/25/2024 | 26.54 | 27.00 | 26.04 | 26.15 | 410,066 | |
| 10/24/2024 | 26.31 | 26.60 | 26.01 | 26.44 | 512,262 | |
| 10/23/2024 | 26.12 | 26.47 | 25.85 | 26.08 | 371,129 | |
| 10/22/2024 | 26.28 | 26.74 | 25.94 | 26.29 | 391,813 | |
| 10/21/2024 | 27.36 | 27.49 | 26.11 | 26.38 | 487,744 | |
| 10/18/2024 | 27.51 | 28.00 | 27.43 | 27.59 | 514,767 | |
| 10/17/2024 | 27.74 | 27.91 | 27.18 | 27.42 | 599,513 | |
| 10/16/2024 | 27.20 | 27.70 | 26.90 | 27.66 | 650,981 | |
| 10/15/2024 | 26.92 | 27.07 | 26.49 | 26.85 | 664,380 | |
| 10/14/2024 | 27.90 | 27.94 | 26.64 | 26.83 | 778,967 | |
| 10/11/2024 | 25.59 | 28.07 | 25.59 | 28.00 | 883,238 | |
| 10/10/2024 | 26.00 | 26.02 | 25.28 | 25.74 | 961,720 | |
| 10/09/2024 | 26.82 | 27.03 | 26.35 | 26.52 | 410,419 | |
| 10/08/2024 | 26.68 | 27.47 | 26.30 | 26.73 | 557,398 | |
| 10/07/2024 | 27.89 | 27.89 | 26.22 | 26.60 | 958,489 | |
| 10/04/2024 | 28.51 | 28.97 | 28.38 | 28.63 | 360,526 | |
| 10/03/2024 | 28.69 | 28.88 | 28.12 | 28.22 | 512,362 | |
| 10/02/2024 | 28.37 | 29.07 | 28.02 | 29.03 | 541,486 | |
| 10/01/2024 | 29.18 | 29.67 | 28.46 | 28.67 | 787,514 | |
| 09/30/2024 | 29.12 | 29.32 | 28.50 | 29.13 | 653,425 | |
| 09/27/2024 | 29.50 | 29.80 | 29.22 | 29.43 | 389,778 | |
| 09/26/2024 | 29.37 | 29.64 | 28.83 | 29.27 | 515,197 | |
| 09/25/2024 | 30.52 | 30.54 | 28.93 | 29.00 | 1,846,956 | |
| 09/24/2024 | 30.24 | 30.51 | 29.58 | 30.32 | 909,464 | |
| 09/23/2024 | 31.23 | 31.28 | 30.23 | 30.24 | 828,926 | |
| 09/20/2024 | 30.94 | 31.24 | 30.65 | 30.91 | 1,997,843 | |
| 09/19/2024 | 31.70 | 31.94 | 30.82 | 31.05 | 943,457 | |
| 09/18/2024 | 30.68 | 32.13 | 30.58 | 30.76 | 1,224,614 | |
| 09/17/2024 | 30.61 | 31.15 | 30.19 | 30.68 | 1,325,728 | |
| 09/16/2024 | 30.77 | 30.96 | 30.12 | 30.33 | 1,141,306 | |
| 09/13/2024 | 28.00 | 31.00 | 28.00 | 30.77 | 2,696,943 | |
| 09/12/2024 | 27.15 | 28.04 | 26.66 | 27.96 | 879,637 | |
| 09/11/2024 | 26.22 | 27.11 | 26.07 | 27.08 | 1,579,680 | |
| 09/10/2024 | 25.71 | 26.40 | 25.34 | 26.34 | 788,008 | |
| 09/09/2024 | 25.27 | 25.81 | 24.85 | 25.59 | 654,894 | |
| 09/06/2024 | 25.29 | 25.50 | 24.47 | 25.25 | 695,238 | |
| 09/05/2024 | 25.25 | 25.40 | 24.78 | 25.25 | 708,799 | |
| 09/04/2024 | 25.17 | 25.69 | 24.62 | 25.16 | 702,013 | |
| 09/03/2024 | 24.36 | 25.48 | 24.24 | 25.12 | 1,439,573 | |
| 08/30/2024 | 24.65 | 24.87 | 24.12 | 24.44 | 763,634 |
About Denali Therapeutics Stock history
Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.4 M | 86.7 M | |
| Net Loss | -293.4 M | -278.7 M |
Denali Therapeutics Quarterly Net Working Capital |
|
Denali Therapeutics Stock Technical Analysis
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Denali Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0319 | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.04 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |